Cardiovascular health: the global challenge.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Bioinformatics-based identification and validation of hub genes associated with aging in patients with coronary artery disease.Aging · 2023
   Article
2. The Possible Role of NLRP3 Inflammasome in Depression and Myocardial Infarction Comorbidity.Journal of personalized medicine · 2023
   Article
3. Mass Customized Outlook for Regenerative Heart Failure Care.International journal of molecular sciences · 2021
   Review
4. Regenerative principles enrich cardiac rehabilitation practice.American journal of physical medicine & rehabilitation · 2014
   Review
5. A network pharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action.PloS one · 2014
   Article
6. Advantages and versatility of fluorescence-based methodology to characterize the functionality of LDLR and class mutation assignment.PloS one · 2014
   Article
7. Inflammation, heart disease, and depression.Current psychiatry reports · 2013
   Review
8. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Vascular health and risk management · 2013
   Review
9. CHD@ZJU: a knowledgebase providing network-based research platform on coronary heart disease.Database : the journal of biological databases and curation · 2013
   Article
10. Energy metabolism plasticity enables stemness programs.Annals of the New York Academy of Sciences · 2012
    Review

Corrections and comments

• Commented on by
  Optimizing revascularization strategies in coronary artery disease for optimal benefit to patients.2011
• Commented on by
  From treating complex coronary artery disease to promoting cardiovascular health: therapeutic transitions and challenges, 2010-2020.2011
• Commented on by
  Pharmacogenomics: application to the management of cardiovascular disease.2011
• Commented on by
  The impact of pharmacogenomics on the management of cardiac disease.2011
• Commented on by
  The Achilles' heel of cardiovascular genetic testing: distinguishing pathogenic mutations from background genetic noise.2011

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as